GILEAD SCIENCES, INC. - Common Stock (GILD)

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common Stock
Shares outstanding
1,240,722,841
Total 13F shares
1,039,326,218
Share change
-6,304,810
Total reported value
$76,098,429,205
Put/Call ratio
93%
Price per share
$73.25
Number of holders
1,705
Value change
-$499,202,917
Number of buys
743
Number of sells
891

Institutional Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q1 2024

As of 31 Mar 2024, GILEAD SCIENCES, INC. - Common Stock (GILD) was held by 1,705 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,039,326,218 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Capital World Investors, Capital Research Global Investors, STATE STREET CORP, Dodge & Cox, GEODE CAPITAL MANAGEMENT, LLC, WELLINGTON MANAGEMENT GROUP LLP, MORGAN STANLEY, and FMR LLC. This page lists 1,706 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.